Status:

COMPLETED

Schistosoma Mansoni Morbidity in Children Aged 1-5 Years

Lead Sponsor:

Makerere University

Collaborating Sponsors:

University of Copenhagen

Conditions:

Intestinal Schistosomiasis

Eligibility:

All Genders

1-5 years

Phase:

PHASE2

Brief Summary

This study is about intestinal schistosomiasis, commonly known as bilharzia, in children aged 1-5 years along Lake Victoria shoreline.The children will be screened for S. mansoni and the effects of th...

Detailed Description

The study has three phases: in the first phase (Phase I) a baseline pretreatment schistosomiasis morbidity assessment of children aged 1-5 years will take place. The Kato-Katz technique will be used t...

Eligibility Criteria

Inclusion

  • 1-5 years

Exclusion

  • \<1-5\> years

Key Trial Info

Start Date :

December 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2014

Estimated Enrollment :

800 Patients enrolled

Trial Details

Trial ID

NCT01901484

Start Date

December 1 2012

End Date

February 1 2014

Last Update

September 17 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Child Health & Development Centre, College of Health Sciences , Makerere University

Kampala, Uganda, 6717

Schistosoma Mansoni Morbidity in Children Aged 1-5 Years | DecenTrialz